Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting ocular diseases with novel APE1/Ref-1 inhibitors

Targeting ocular diseases with novel APE1/Ref-1 inhibitors

US Patent 11723886 · Granted Aug 15, 2023

Estimated economic value: $600,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of APE1/Ref-1 inhibitors for treatment of retinal diseases2025
Ferrochelatase inhibitors and methods of use2024
Composition for blocking angiogenesis2023
Use of APE1/Ref-1 inhibitors for treatment of retinal diseases2023
Prevention and reversal of inflammation induced DNA damage2022
Benzoquinone derivative E3330 in combination with chemotherapeutic agents for th2022
Compounds, compositions and methods for treating oxidative DNA damage disorders2021
Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes2020
Inhibition of ferrochelatase as an antiangiogenic therapy2020
Compounds for treatment of angiogenesis-mediated diseases2020
Compounds for treatment of angiogenesis-mediated diseases2019
Quinone compounds for treating APE1 mediated diseases2018